DBS Assay with LC-MS/MS for the Determination of Idelalisib, A Selective PI3K-δ Inhibitor in Mice Blood and Its Application to a Pharmacokinetic Study.

Tripathy HK, Manju NSV, Dittakavi S, Zakkula A, Mullangi R

Open source

DOI
10.1055/a-1252-2476
Published
2021 Jan
Container
Drug research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/a-1252-2476,
  title = {DBS Assay with LC-MS/MS for the Determination of Idelalisib, A Selective PI3K-δ Inhibitor in Mice Blood and Its Application to a Pharmacokinetic Study.},
  author = {Tripathy HK and Manju NSV and Dittakavi S and Zakkula A and Mullangi R},
  year = {2021},
  journal = {Drug research},
  doi = {10.1055/a-1252-2476},
  url = {https://doi.org/10.1055/a-1252-2476}
}

RIS

TY  - JOUR
TI  - DBS Assay with LC-MS/MS for the Determination of Idelalisib, A Selective PI3K-δ Inhibitor in Mice Blood and Its Application to a Pharmacokinetic Study.
AU  - Tripathy HK
AU  - Manju NSV
AU  - Dittakavi S
AU  - Zakkula A
AU  - Mullangi R
PY  - 2021
JO  - Drug research
DO  - 10.1055/a-1252-2476
UR  - https://doi.org/10.1055/a-1252-2476
ER  - 

APA

HK, T., NSV, M., S, D., A, Z., & R, M. (2021). DBS Assay with LC-MS/MS for the Determination of Idelalisib, A Selective PI3K-δ Inhibitor in Mice Blood and Its Application to a Pharmacokinetic Study.. Drug research. https://doi.org/10.1055/a-1252-2476

Source records